Key Findings:  This is the first study to report the involvement of neuronal proteins and nerve growth factor (NGF) receptors (trkA) in the neuroprotection of CBD. Findings suggest that CBD has a neurorestorative potential independent of NGF that might contribute to its neuroprotection against 1-methyl-4-phenylpyridinium iodide [MPP(+)], a neurotoxin relevant to Parkinson's disease.
Type of Study:  Laboratory Study
Study Result:  Positive
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype III